Vimarsana
Biggest News Aggregation in the World

Page 10 - Priya Singhal News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Priya Singhal. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Priya Singhal Today - Breaking & Trending Today

Biogen (NASDAQ:BIIB) Issues FY24 Earnings Guidance - Vimarsana News

Biogen (NASDAQ:BIIB) Issues FY24 Earnings Guidance

Biogen (NASDAQ:BIIB – Get Free Report) updated its FY24 earnings guidance on Wednesday. The company provided earnings per share guidance of $15.00-16.00 for the period, compared to the consensus earnings per share estimate of $15.49. The company issued revenue guidance of decline low- to mid-single digits, compared to the consensus revenue estimate of $9.47 billion. […]

Biogen (NASDAQ:BIIB) Releases FY24 Earnings Guidance - Vimarsana News

Biogen (NASDAQ:BIIB) Releases FY24 Earnings Guidance

Biogen (NASDAQ:BIIB – Get Free Report) issued an update on its FY24 earnings guidance on Wednesday morning. The company provided earnings per share guidance of $15.00-16.00 for the period, compared to the consensus earnings per share estimate of $15.49. The company issued revenue guidance of decline low- to mid-single digits, compared to the consensus revenue […]

Harvest Fund Management Co. Ltd Purchases 133 Shares of Biogen Inc. (NASDAQ:BIIB) - Vimarsana News

Harvest Fund Management Co. Ltd Purchases 133 Shares of Biogen Inc. (NASDAQ:BIIB)

Harvest Fund Management Co. Ltd raised its stake in Biogen Inc. (NASDAQ:BIIB – Free Report) by 11.5% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,290 shares of the biotechnology company’s stock after purchasing an additional 133 shares during the […]

Alzheimer's drug adoption in US slowed by doctors' skepticism | WSAU News/Talk 550 AM · 99.9 FM - Vimarsana News

Alzheimer's drug adoption in US slowed by doctors' skepticism | WSAU News/Talk 550 AM · 99.9 FM

(Repeats to additional subscribers with no changes to text ) By Julie Steenhuysen CHICAGO (Reuters) -Nine months into the U.S. launch of the first drug proven to slow the advance of Alzheimer's, Eisai and Biogen's Leqembi is facing an unexpected hurdle...

Source: wsau.com
Alzheimer's treatment: Drug adoption slow in U.S. - Vimarsana News

Alzheimer's treatment: Drug adoption slow in U.S.

Nine months into the U.S. launch of the first drug proven to slow the advance of Alzheimer's, Eisai and Biogen's Leqembi is facing an unexpected hurdle to widespread use: an entrenched belief among some doctors that treating the memory-robbing disease is futile.

Source: ctvnews.ca